Susanna Cappelli

1.2k total citations
17 papers, 621 citations indexed

About

Susanna Cappelli is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Susanna Cappelli has authored 17 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Susanna Cappelli's work include Systemic Sclerosis and Related Diseases (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Protist diversity and phylogeny (2 papers). Susanna Cappelli is often cited by papers focused on Systemic Sclerosis and Related Diseases (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Protist diversity and phylogeny (2 papers). Susanna Cappelli collaborates with scholars based in Italy, France and United States. Susanna Cappelli's co-authors include Marco Matucci‐Cerinic, Serena Guiducci, Paola Caramaschi, Jean Sibilia, André Kahan, Yannick Allanore, Philippe Dieudé, Élisabeth Diot, Alessandra Vacca and K.P. Tiev and has published in prestigious journals such as Lara D. Veeken, Frontiers in Genetics and Spinal Cord.

In The Last Decade

Susanna Cappelli

16 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanna Cappelli Italy 10 444 337 90 78 74 17 621
Els Vandecasteele Belgium 16 430 1.0× 243 0.7× 159 1.8× 116 1.5× 113 1.5× 33 768
Kathleen Morrisroe Australia 17 687 1.5× 456 1.4× 106 1.2× 170 2.2× 112 1.5× 57 876
Alessandro Sgreccia Italy 15 191 0.4× 294 0.9× 59 0.7× 157 2.0× 43 0.6× 36 623
Suzanne Kafaja United States 11 346 0.8× 207 0.6× 65 0.7× 96 1.2× 106 1.4× 25 505
Nemanja Damjanov Serbia 12 428 1.0× 195 0.6× 84 0.9× 127 1.6× 108 1.5× 19 545
Enrico Tirri Italy 9 615 1.4× 224 0.7× 79 0.9× 176 2.3× 185 2.5× 12 778
Cornelis Kallenberg Netherlands 13 211 0.5× 178 0.5× 117 1.3× 103 1.3× 175 2.4× 45 752
Alexander Rozin Israel 14 191 0.4× 121 0.4× 69 0.8× 115 1.5× 105 1.4× 50 649
Can Huang China 13 112 0.3× 240 0.7× 117 1.3× 120 1.5× 53 0.7× 70 651
Ali Akdoğan Türkiye 15 124 0.3× 123 0.4× 83 0.9× 65 0.8× 138 1.9× 46 576

Countries citing papers authored by Susanna Cappelli

Since Specialization
Citations

This map shows the geographic impact of Susanna Cappelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanna Cappelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanna Cappelli more than expected).

Fields of papers citing papers by Susanna Cappelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanna Cappelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanna Cappelli. The network helps show where Susanna Cappelli may publish in the future.

Co-authorship network of co-authors of Susanna Cappelli

This figure shows the co-authorship network connecting the top 25 collaborators of Susanna Cappelli. A scholar is included among the top collaborators of Susanna Cappelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanna Cappelli. Susanna Cappelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Costagliola, Giorgio, Sofia D’Elios, Susanna Cappelli, et al.. (2024). Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicism. Frontiers in Pediatrics. 12. 1379616–1379616. 1 indexed citations
2.
Cappelli, Susanna, Alice Bonuccelli, Sofia D’Elios, et al.. (2023). Ataxia Telangiectasia Arising as Immunodeficiency: The Intriguing Differential Diagnosis. Journal of Clinical Medicine. 12(18). 6041–6041. 3 indexed citations
3.
Cappelli, Susanna, Alessandro Orsini, Alice Bonuccelli, et al.. (2021). Toward the Knowledge of the Epidemiological Impact of Acute Rheumatic Fever in Italy. Frontiers in Pediatrics. 9. 746505–746505. 4 indexed citations
4.
Costagliola, Giorgio, Susanna Cappelli, & Rita Consolini. (2021). Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical Implications. Journal of Clinical Medicine. 10(20). 4729–4729. 37 indexed citations
5.
Costagliola, Giorgio, Susanna Cappelli, & Rita Consolini. (2020). <p>Behçet’s Disease in Children: Diagnostic and Management Challenges</p>. Therapeutics and Clinical Risk Management. Volume 16. 495–507. 21 indexed citations
7.
Gana, Simone, Angelo Valetto, Benedetta Toschi, et al.. (2019). Familial Interstitial 6q23.2 Deletion Including Eya4 Associated With Otofaciocervical Syndrome. Frontiers in Genetics. 10. 650–650. 6 indexed citations
8.
Cappelli, Susanna, Philippe Guilpain, G. Fiori, et al.. (2015). Transitional Connective Tissue Diseases: Description of Four Cases. Current Rheumatology Reviews. 10(2). 94–98.
9.
Cappelli, Susanna, Silvia Bellando-Randone, Gianna Camiciottoli, et al.. (2015). Interstitial lung disease in systemic sclerosis: where do we stand?. European Respiratory Review. 24(137). 411–419. 77 indexed citations
10.
Cappelli, Susanna, et al.. (2013). Immunosuppression for interstitial lung disease in systemic sclerosis. European Respiratory Review. 22(129). 236–243. 20 indexed citations
11.
Cappelli, Susanna, et al.. (2013). Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?. Lara D. Veeken. 53(6). 975–987. 18 indexed citations
12.
Meune, Christophe, Jérôme Avouac, Paolo Airó, et al.. (2011). Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis & Rheumatism. 63(9). 2790–2796. 50 indexed citations
13.
Avouac, Jérôme, Paolo Airó, Philippe Dieudé, et al.. (2010). Associated Autoimmune Diseases in Systemic Sclerosis Define a Subset of Patients with Milder Disease: Results from 2 Large Cohorts of European Caucasian Patients. The Journal of Rheumatology. 37(3). 608–614. 56 indexed citations
14.
Avouac, Jérôme, Christophe Meune, Lorenzo Beretta, et al.. (2010). Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies. The Journal of Rheumatology. 37(11). 2290–2298. 218 indexed citations
15.
Aito, S, et al.. (2006). Neurological and functional outcome in traumatic central cord syndrome. Spinal Cord. 45(4). 292–297. 81 indexed citations
16.
Schietroma, Mario, et al.. (2005). [Parathyroidectomy: bilateral exploration of the neck vs minimally invasive radioguided treatment].. PubMed. 60(2). 83–9. 8 indexed citations
17.
Forman, Walter B., et al.. (1990). Zinc abuse--an unsuspected cause of sideroblastic anemia.. PubMed. 152(2). 190–2. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026